XSS in Philips Patient Information Center Ix
CVE-2020-16218
In Patient Information Center iX (PICiX) Versions B.02, C.02, C.03, the software does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is then used as a webpage and served to other users. Successful exploitation could lead to unauthorized access to patient data via a read-only web application.
Vulnerability class: XSS (Cross-Site Scripting)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 3.5 (Low). Vector: CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N.
EPSS exploit prediction
EPSS: 0.007 (49.3th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 49th percentile — 49.3% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.007 · newest: 0.007 · change: 0.000
Affected products
- Philips Patient Information Center Ix — versions b.02, c.02, c.03
- Philips Patient Information Center Ix (Picix) — versions B.02, C.02, C.03
Weakness classification (CWE)
Public proof-of-concept exploits
References
- us-cert.cisa.gov/ics/advisories/icsma-20-254-01 (US Government Resource, Third Party Advisory)
- www.philips.com/productsecurity
Frequently asked questions
- What is CVE-2020-16218?
- CVE-2020-16218 is a low-severity vulnerability in Philips Patient Information Center Ix, classified under Cross-site Scripting. CVSS score: 3.5/10. Published 2020-09-11.
- How severe is CVE-2020-16218?
- Low severity. CVSS v3 base score is 3.5 out of 10.
- Is CVE-2020-16218 known to be exploited?
- 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.